Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects.

Front Cardiovasc Med · 2025 · PMC12011764 · PMID 40264510

Europe PMC DOI

hedged sentence

0.0940

closest p · 1.9× alpha

0.0940

boldest claim

The sentences

a nonsignificant trendp = 0.094so close (0.05 < p ≤ 0.1)

−1.43%, p = 0.025), with a nonsignificant trend of resolution of hepatic steatosis (44.9% vs. 28.6%, p = 0.094) ( 124 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.